Botanical phenolics and neurodegeneration

Herbal Medicine: Biomolecular and Clinical Aspects: Second Edition

Volumn , Issue , 2011, Pages 315-332

  Sun, Albert Y ^a   Wang, Qun ^a   Simonyi, Agnes ^a   Sun, Grace Y ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019531924     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (174)

1. Abekawa, T., T. Ohmori, and T. Koyama. 1997. Tolerance to the neurotoxic effect of methamphetamine in rats behaviorally sensitized to methamphetamine or amphetamine. Brain Res 767:34-44.
2. Adams Jr., J. D., and I. N. Odunze. 1991. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: Could oxidative stress be involved in the brain? Biochem Pharmacol 41:1099-105.
3. Akama, K. T., and L. J. Van Eldik. 2000. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275:7918-24.
4. Al-Omar, F. A., M. N. Nagi, M. M. Abdulgadir, K. S. Al Joni, and A. A. Al-Majed. 2006. Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus. Neurochem Res 31:611-8.
5. Aminoff, M. J. 2007. Pharmacologic management of parkinsonism and other movement disorders. In: Katzung B.G., editor. Basic and Clinical Pharmacology, 10th ed. New York: McGraw-Hill, Lange Medical; pp. 442-451.
6. Anantharam, V., S. Kaul, C. Song, A. Kanthasamy, and A. G. Kanthasamy. 2007. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 28:988-97.
7. Anekonda, T. S. 2006. Resveratrol-a boon for treating Alzheimer's disease? Brain Res Rev 52:316-26.
8. Anekonda, T. S., and P. H. Reddy. 2005. Can herbs provide a new generation of drugs for treating Alzheimer's disease? Brain Res Brain Res Rev 50:361-76.
9. Anekonda, T. S., and P. H. Reddy. 2006. Neuronal protection by sirtuins in Alzheimer's disease. J Neurochem 96:305-13.
10. Ashe, K. H. 2005. Mechanisms of memory loss in Abeta and tau mouse models. Biochem Soc Trans 33:591-4.
11. Barghorn, S., V. Nimmrich, A. Striebinger et al. 2005. Globular amyloid beta-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95:834-47.
12. Bastianetto, S., and R. Quirion. 2004. Natural antioxidants and neurodegenerative diseases. Front Biosci 9:3447-52.
13. Baur, J. A., K. J. Pearson, N. L. Price et al. 2006. Resveratrol improves health and survival of mice on a highcalorie diet. Nature 444:337-42.
14. Baur, J. A., and D. A. Sinclair. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5:493-506.
15. Begum, A. N., M. R. Jones, G. P. Lim et al. 2008. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326:196-208.
16. Bi, X. L., J. Y. Yang, Y. X. Dong et al. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int Immunopharmacol 5:185-93.
17. Block, M. L. 2008. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9(Suppl. 2):S8.
18. Bravo, L. 1998. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56:317-33.
19. Butterfield, D. A. 2002. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36:1307-13.
20. Butterfield, D. A., A. Castegna, C. M. Lauderback, and J. Drake. 2002a. Evidence that amyloid beta-peptideinduced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23:655-64.
21. Butterfield, D. A., S. Griffin, G. Munch, and G. M. Pasinetti. 2002b. Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis 4:193-201.
22. Calabrese, V., C. Cornelius, C. Mancuso et al. 2008. Cellular stress response: A novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res 33:2444-71.
23. Calabrese, V., C. Cornelius, C. Mancuso et al. 2009. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci 14:376-97.
24. Castano, A., A. J. Herrera, J. Cano, and A. Machado. 1998. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem 70:1584-92.
25. Chanvitayapongs, S., B. Draczynska-Lusiak, and A. Y. Sun. 1997. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 8:1499-502.
26. Chauhan, N. B., and J. Sandoval. 2007. Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice. Phytother Res 21:629-40.
27. Chen, H. Q., Z. Y. Jin, and G. H. Li. 2007. Biochanin a protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci Lett 417:112-7.
28. Chen, H., Y. S. Song, and P. H. Chan. 2009. Inhibition of NADPH oxidase is neuroprotective after ischemiareperfusion. J Cereb Blood Flow Metab 29:1262-72.
29. Chen, J., X. Q. Tang, J. L. Zhi et al. 2006. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11:943-53.
30. Choi, Y. B., Y. I. Kim, K. S. Lee, B. S. Kim, and D. J. Kim. 2004. Protective effect of epigallocatechin gallate on brain damage after transient middle cerebral artery occlusion in rats. Brain Res 1019:47-54.
31. Choi, S. Y., S. Kim, D. Son et al. 2007. Protective effect of (4-methoxybenzylidene)-(3-methoxynophenyl) amine against neuronal cell death induced by oxygen and glucose deprivation in rat organotypic hippocampal slice culture. Biol Pharm Bull 30:189-92.
32. Choi, J. Y., C. S. Park, D. J. Kim et al. 2002. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 23:367-74.
33. Chung, W. G., C. L. Miranda, and C. S. Maier. 2007. Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Res 1176:133-42.
34. Cohen, H. Y., C. Miller, K. J. Bitterman et al. 2004. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-2.
35. Conte, A., S. Pellegrini, and D. Tagliazucchi. 2003. Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res Bull 62:29-38.
36. Contestabile, A., E. Ciani, and A. Contestabile. 2008. The place of choline acetyltransferase activity measurement in the "cholinergic hypothesis" of neurodegenerative diseases. Neurochem Res 33:318-27.
37. Cristovao, A. C., D. Choi, G. Baltazar, F. Beal, and Y. S. Kim. 2009. The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11(9):2105-18.
38. Curin, Y., M. F. Ritz, and R. Andriantsitohaina. 2006. Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc Hematol Agents Med Chem 4:277-88.
39. Deschamps, V., P. Barberger-Gateau, E. Peuchant, and J. M. Orgogozo. 2001. Nutritional factors in cerebral aging and dementia: Epidemiological arguments for a role of oxidative stress. Neuroepidemiology 20:7-15.
40. Dohare, P., P. Garg, V. Jain, C. Nath, and M. Ray. 2008. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav Brain Res 193:289-97.
41. Doverhag, C., M. Keller, A. Karlsson et al. 2008. Pharmacological and genetic inhibition of NADPH oxidase does not reduce brain damage in different models of perinatal brain injury in newborn mice. Neurobiol Dis 31:133-44.
42. Farooqui, T., and A. A. Farooqui. 2009. Aging: An important factor for the pathogenesis of neurodegenerative diseases. Mech Ageing Dev 130:203-15.
43. Feng, Y., Y. M. Liu, M. H. Leblanc, A. J. Bhatt, and P. G. Rhodes. 2007. Grape seed extract given three hours after injury suppresses lipid peroxidation and reduces hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 61:295-300.
44. Fiala, M., D. H. Cribbs, M. Rosenthal, and G. Bernard. 2007. Phagocytosis of amyloid-beta and inflammation: Two faces of innate immunity in Alzheimer's disease. J Alzheimers Dis 11:457-63.
45. Frautschy, S. A., W. Hu, P. Kim et al. 2001. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 22:993-1005.
46. Gao, D., X. Zhang, X. Jiang et al. (2006) Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 78:2564-70.
47. Ghoneim, A. I., A. B. Abdel-Naim, A. E. Khalifa, and E. S. El-Denshary. 2002. Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 46:273-9.
48. Goel, A., A. B. Kunnumakkara, and B. B. Aggarwal. 2008. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 75:787-809.
49. Gonzalez-Hernandez, T., M. A. Perez de la Cruz, and B. Mantolan-Sarmiento. 1996. Histochemical and immunohistochemical detection of neurons that produce nitric oxide: Effect of different fixative parameters and immunoreactivity against non-neuronal NOS antisera. J Histochem Cytochem 44:1399-413.
50. Howes, M. J., and P. J. Houghton. 2003. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75:513-27.
51. Howes, M. J., N. S. Perry, and P. J. Houghton. 2003. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 17:1-18.
52. Howitz, K. T., K. J. Bitterman, H. Y. Cohen et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-6.
53. Huang, S. S., M. C. Tsai, C. L. Chih, L. M. Hung, and S. K. Tsai. 2001. Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 69:1057-65.
54. Hwang, I. K., K. Y. Yoo, D. S. Kim et al. 2004. Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia. Life Sci 75:1989-2001.
55. Inoue, H., X. F. Jiang, T. Katayama, S. Osada, K. Umesono, and S. Namura. 2003. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice. Neurosci Lett 352:203-6.
56. Jackman, K. A., A. A. Miller, T. M. De Silva, P. J. Crack, G. R. Drummond, and C. G. Sobey. 2009. Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br J Pharmacol 156:680-8.
57. Jagatha, B., R. B. Mythri, S. Vali, and M. M. Bharath. 2008. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: Therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med 44:907-17.
58. 2 derived from NADPH oxidase: A cell culture study. J Neuroinflammation 3:24.
59. Jiang, J., W. Wang, Y. J. Sun, M. Hu, F. Li, and D. Y. Zhu. 2007. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 561:54-62.
60. Jin, F., Q. Wu, Y. F. Lu, Q. H. Gong, and J. S. Shi. 2008. Neuroprotective effect of resveratrol on 6-OHDAinduced Parkinson's disease in rats. Eur J Pharmacol 600:78-82.
61. Kahles, T., P. Luedike, M. Endres et al. 2007. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38:3000-6.
62. Kelly, K. A., X. Li, Z. Tan, R. L. VanGilder, C. L. Rosen, and J. D. Huber. 2009. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res 1292:165-72.
63. Kim, C. Y., C. Lee, G. H. Park, and J. H. Jang. 2009. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch Pharm Res 32:869-81.
64. Kim, Y. A., S. Y. Lim, S. H. Rhee et al. (2006) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 17:1069-75.
65. Kim, D., M. D. Nguyen, M. M. Dobbin et al. 2007. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. Embo J 26:3169-79.
66. Koshimura, I., H. Imai, T. Hidano et al. 1997. Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system. Brain Res 773:108-16.
67. Kryscio, R. J., M. S. Mendiondo, F. A. Schmitt, and W. R. Markesbery. 2004. Designing a large prevention trial: Statistical issues. Stat Med 23:285-96.
68. Kryscio, R. J., F. A. Schmitt, J. C. Salazar, M. S. Mendiondo, and W. R. Markesbery. 2006. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 66:828-32.
69. Lamming, D. W., J. G. Wood, and D. A. Sinclair. 2004. Small molecules that regulate lifespan: Evidence for xenohormesis. Mol Microbiol 53:1003-9.
70. Langston, J. W. 1987. MPTP: Insights into the etiology of Parkinson's disease. Eur Neurol 26(Suppl 1):2-10.
71. Lau, F. C., B. Shukitt-Hale, and J. A. Joseph. 2005. The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging 26(Suppl. 1):128-32.
72. Leaver, K. R., H. N. Allbutt, N. J. Creber, M. Kassiou, and J. M. Henderson. 2009. Oral pre-treatment with epigallocatechin gallate in 6-OHDA lesioned rats produces subtle symptomatic relief but not neuroprotection. Brain Res Bull 80:397-402.
73. Lee, H., J. H. Bae, and S. R. Lee. 2004. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res 77:892-900.
74. Lee, H. S., K. K. Jung, J. Y. Cho et al. 2007. Neuroprotective effect of curcumin is mainly mediated by blockade of microglial cell activation. Pharmazie 62:937-42.
75. Lee, S. Y., C. Y. Kim, J. J. Lee, J. G. Jung, and S. R. Lee. 2003. Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res Bull 61:399-406.
76. Lee, J. W., Y. K. Lee, J. O. Ban et al. 2009. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloidinduced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J Nutr 139:1987-93.
77. Lee, S., S. Suh, and S. Kim. 2000. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 287:191-4.
78. Levites, Y., O. Weinreb, G. Maor, M. B. Youdim, and S. Mandel. 2001. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78:1073-82.
79. Lim, G. P., T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370-7.
80. Lin, C. L., T. F. Chen, M. J. Chiu, T. D. Way, and J. K. Lin. 2009. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation. Neurobiol Aging 30:81-92.
81. Lu, K. T., R. Y. Chiou, L. G. Chen et al. 2006. Neuroprotective effects of resveratrol on cerebral ischemiainduced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem 54:3126-31.
82. Lu, K. T., M. C. Ko, B. Y. Chen et al. 2008. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56:6910-3.
83. Mancuso, C., T. E. Bates, D. A. Butterfield et al. 2007. Natural antioxidants in Alzheimer's disease. Expert Opin Investig Drugs 16:1921-31.
84. Mandel, S. A., T. Amit, L. Kalfon, L. Reznichenko, O. Weinreb, and M. B. Youdim. 2008a. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: Special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 15:211-22.
85. Mandel, S. A., T. Amit, L. Kalfon, L. Reznichenko, and M. B. Youdim. 2008b. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J Nutr 138:1578S-83S.
86. Mandel, S., G. Maor, and M. B. Youdim. 2004. Iron and alpha-synuclein in the substantia nigra of MPTP-treated mice: Effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J Mol Neurosci 24:401-16.
87. Mandel, S., and M. B. Youdim. 2004. Catechin polyphenols: Neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37:304-17.
88. Mander, P. K., A. Jekabsone, and G. C. Brown. 2006. Microglia proliferation is regulated by hydrogen peroxide from NADPH oxidase. J Immunol 176:1046-52.
89. Marambaud, P., H. Zhao, and P. Davies. 2005. Resveratrol promotes clearance of Alzheimer's disease amyloidbeta peptides. J Biol Chem 280:37377-82.
90. Martin, S., E. Andriambeloson, K. Takeda, and R. Andriantsitohaina. 2002. Red wine polyphenols increase calcium in bovine aortic endothelial cells: A basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 135:1579-87.
91. Mattson, M. P. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631-9.
92. McKeel Jr., D. W., J. L. Price, J. P. Miller et al. 2004. Neuropathologic criteria for diagnosing Alzheimer's disease in persons with pure dementia of Alzheimer type. J Neuropathol Exp Neurol 63:1028-37.
93. Mercer, L. D., B. L. Kelly, M. K. Horne, and P. M. Beart. 2005. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem Pharmacol 69:339-45.
94. Miller, R. L., M. James-Kracke, G. Y. Sun, and A. Y. Sun. 2009. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 34:55-65.
95. Miller, R. L., G. Y. Sun, and A. Y. Sun. 2007. Cytotoxicity of paraquat in microglial cells: Involvement of PKCdelta- and ERK1/2-dependent NADPH oxidase. Brain Res 1167:129-39.
96. Ndiaye, M., M. Chataigneau, I. Lobysheva, T. Chataigneau, and V. B. Schini-Kerth. 2005. Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J 19:455-7.
97. Ono, K., T. Hamaguchi, H. Naiki, and M. Yamada. 2006a. Anti-amyloidogenic effects of antioxidants: Implications for the prevention and therapeutics of Alzheimer's disease. Biochim Biophys Acta 1762:575-86.
98. Ono, K., K. Hasegawa, H. Naiki, and M. Yamada. 2004. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75:742-50.
99. Ono, K., H. Naiki, and M. Yamada. 2006b. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta. Curr Pharm Des 12:4357-75.
100. Pallas, M., G. Casadesus, M. A. Smith et al. 2009. Resveratrol and neurodegenerative diseases: Activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6:70-81.
101. Pandey, N., J. Strider, W. C. Nolan, S. X. Yan, and J. E. Galvin. 2008. Curcumin inhibits aggregation of alphasynuclein. Acta Neuropathol 115:479-89.
102. Park, J. W., Y. H. Jang, J. M. Kim et al. 2009. Green tea polyphenol (-)-epigallocatechin gallate reduces neuronal cell damage and up-regulation of MMP-9 activity in hippocampal CA1 and CA2 areas following transient global cerebral ischemia. J Neurosci Res 87:567-75.
103. Parker, J. A., M. Arango, S. Abderrahmane et al. 2005. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37:349-50.
104. Peng, J., F. F. Stevenson, M. L. Oo, and J. K. Andersen. 2009. Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. Free Radic Biol Med 46:312-20.
105. Perry, G., A. Nunomura, K. Hirai et al. 2002. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 33:1475-9.
106. Pu, F., K. Mishima, K. Irie et al. 2007. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104:329-34.
107. Qin, B., L. Cartier, M. Dubois-Dauphin, B. Li, L. Serrander, and K. H. Krause. 2006. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging 27:1577-87.
108. Rahman, I., S. K. Biswas, and P. A. Kirkham. 2006. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-52.
109. Rahman, R. M., S. M. Nair, S. C. Helps et al. 2005. (-)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia. Neurosci Lett 382:227-30.
110. Rajeswari, A. 2006. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur Rev Med Pharmacol Sci 10:157-61.
111. Rajeswari, A., and M. Sabesan. 2008. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16:96-9.
112. Ramassamy, C. 2006. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. Eur J Pharmacol 545:51-64.
113. Raskin, I., D. M. Ribnicky, S. Komarnytsky et al. 2002. Plants and human health in the twenty-first century. Trends Biotechnol 20:522-31.
114. Rasoolijazi, H., M. T. Joghataie, M. Roghani, and M. Nobakht. 2007. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rats: A behavioral analysis. Iran Biomed J 11:237-43.
115. Rasouri, S., M. Lagouge, and J. Auwerx. 2007. SIRT1/PGC-1: A neuroprotective axis? Med Sci (Paris) 23:840-4.
116. Raval, A. P., K. R. Dave, and M. A. Perez-Pinzon. 2006. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26:1141-7.
117. Rezai-Zadeh, K., G. W. Arendash, H. Hou et al. 2008. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 1214:177-87.
118. Rezai-Zadeh, K., D. Shytle, N. Sun et al. 2005. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807-14.
119. Rice-Evans, C., and N. Miller. 1997. Measurement of the antioxidant status of dietary constituents, low density lipoproteins and plasma. Prostaglandins Leukot Essent Fatty Acids 57:499-505.
120. Ringman, J. M., S. A. Frautschy, G. M. Cole, D. L. Masterman, and J. L. Cummings. 2005. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2:131-6.
121. Rubiolo, J. A., G. Mithieux, and F. V. Vega. 2008. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 591:66-72.
122. Saiko, P., A. Szakmary, W. Jaeger, and T. Szekeres. 2008. Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658:68-94.
123. Salmina, A. B. 2009. Neuron-glia interactions as therapeutic targets in neurodegeneration. J Alzheimers Dis 16:485-502.
124. Salvioli, S., E. Sikora, E. L. Cooper, and C. Franceschi. 2007. Curcumin in cell death processes: A challenge for CAM of age-related pathologies. Evid Based Complement Alternat Med 4:181-90.
125. Schapira, A. H. 1996. Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Adv Neurol 69:161-5.
126. Selkoe, D. J., and M. B. Podlisny. 2002. Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genomics Hum Genet 3:67-99.
127. Sharma, M., and Y. K. Gupta. 2002. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489-98.
128. Shelat, P. B., M. Chalimoniuk, J. H. Wang et al. 2008. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 106:45-55.
129. Shimmyo, Y., T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto. 2008. Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuroreport 19:1329-33.
130. Shukla, P. K., V. K. Khanna, M. M. Ali, M. Y. Khan, and R. C. Srimal. 2008. Anti-ischemic effect of curcumin in rat brain. Neurochem Res 33:1036-43.
131. Simonyi, A., Q. Wang, R. L. Miller et al. 2005. Polyphenols in cerebral ischemia: Novel targets for neuroprotection. Mol Neurobiol 31:135-47.
132. Sinclair, D. 2005. Sirtuins for healthy neurons. Nat Genet 37:339-40.
133. Sinha, K., G. Chaudhary, and Y. K. Gupta. 2002. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71:655-65.
134. Small, D. H. 2001. Biomarkers of Alzheimer's disease: Bridging the gap between basic science and clinical practice. J Alzheimers Dis 3:257-9.
135. Small, D. H., S. S. Mok, and J. C. Bornstein. 2001. Alzheimer's disease and Abeta toxicity: From top to bottom. Nat Rev Neurosci 2:595-8.
136. 2+ release in the 3xTg-AD mouse model of Alzheimer's disease. J Neurochem 94:1711-8.
137. Sorce, S., and K. H. Krause. 2009. NOX enzymes in the central nervous system: From signaling to disease. Antioxid Redox Signal 11(10):2481-504.
138. Suh, S. W., B. S. Shin, H. Ma et al. 2008. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 64:654-63.
139. Sun, A., and J. Cheng. 1999. Novel targets for therapeutic intervention against ischemic brain injury. Clin Neuropharmacol 22:164-71.
140. Sun, A. Y., Q. Wang, A. Simonyi, and G. Y. Sun. 2008. Botanical phenolics and brain health. Neuromolecular Med 10:259-74.
141. Sun, G. Y., J. Xia, B. Draczynska-Lusiak, A. Simonyi, and A. Y. Sun. 1999. Grape polyphenols protect neurodegenerative changes induced by chronic ethanol administration. Neuroreport 10:93-6.
142. Sun, A. Y., W. L. Yang, and H. D. Kim. 1993. Free radical and lipid peroxidation in manganese-induced neuronal cell injury. Ann N Y Acad Sci 679:358-63.
143. Sutherland, B. A., O. M. Shaw, A. N. Clarkson, D. N. Jackson, I. A. Sammut, and I. Appleton. 2005. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: Novel mechanisms of action. FASEB J 19:258-60.
144. Takada-Takatori, Y., T. Kume, Y. Izumi et al. 2009. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biol Pharm Bull 32:318-24.
145. Takahashi, R. H., C. G. Almeida, P. F. Kearney et al. 2004. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-9.
146. Tang, X. N., B. Cairns, N. Cairns, and M. A. Yenari. 2008. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 154:556-62.
147. Tang, L. L., K. Ye, X. F. Yang, and J. S. Zheng. 2007. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J Int Med Res 35:517-22.
148. Terry, R. D., E. Masliah, D. P. Salmon et al. 1991. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-80.
149. Thiyagarajan, M., and S. S. Sharma. 2004. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 74:969-85.
150. Tipton, K. F., and T. P. Singer. 1993. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61:1191-206.
151. Tissenbaum, H. A., and L. Guarente. 2001. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410:227-30.
152. Tsai, S. K., L. M. Hung, Y. T. Fu et al. 2007. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46:346-53.
153. Voko, Z., M. Hollander, A. Hofman, P. J. Koudstaal, and M. M. Breteler. 2003. Dietary antioxidants and the risk of ischemic stroke: The Rotterdam study. Neurology 61:1273-5.
154. Wang, J., L. Ho, Z. Zhao et al. 2006. Moderate consumption of cabernet sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20:2313-20.
155. Wang, Q., A. Simonyi, W. Li et al. 2005a. Dietary grape supplement ameliorates cerebral ischemia-induced neuronal death in gerbils. Mol Nutr Food Res 49:443-51.
156. Wang, Q., A. Y. Sun, A. Simonyi et al. 2005b. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res 82:138-48.
157. Wang, Q., K. D. Tompkins, A. Simonyi, R. J. Korthuis, A. Y. Sun, and G. Y. Sun. 2006. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090:1829.
158. Wang, Q., J. Xu, G. E. Rottinghaus et al. 2002. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958:439-47.
159. Wang, Q., S. Yu, A. Simonyi, G. Rottinghaus, G. Y. Sun, and A. Y. Sun. 2004. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem Res 29:2105-12.
160. Wang, Q., S. Yu, A. Simonyi, G. Y. Sun, and A. Y. Sun. 2005c. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3-16.
161. Weinreb, O., S. Mandel, T. Amit, and M. B. Youdim. 2004. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem 15:506-16.
162. Wood, J. G., B. Rogina, S. Lavu et al. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686-9.
163. Yang, F., G. P. Lim, A. N. Begum et al. 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-901.
164. Yang, C., X. Zhang, H. Fan, and Y. Liu. 2009. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282:133-41.
165. You, H., and T. W. Mak. 2005. Crosstalk between p53 and FOXO transcription factors. Cell Cycle 4:37-8.
166. Youdim, M. B. 2003. What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? J Neural Transm Suppl (65):73-88.
167. Youdim, K. A., and J. A. Joseph. 2001. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects. Free Radic Biol Med 30:583-94.
168. Zbarsky, V., K. P. Datla, S. Parkar, D. K. Rai, O. I. Aruoma, and D. T. Dexter. 2005. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 39:1119-25.
169. Zerbinatti, C. V., D. F. Wozniak, J. Cirrito et al. 2004. Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein. Proc Natl Acad Sci 101:1075-80.
170. Zhang, D., X. Hu, S. J. Wei et al. 2008. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. J Neuroinflammation 5:21.
171. Zhao, J., Yu, S., Zheng, W., Feng, G., Luo, G., Wang, L. and Zhao, Y. 2010. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 35:374-379.
172. Zhao, J., Y. Zhao, W. Zheng, Y. Lu, G. Feng, and S. Yu. 2008. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 1229:224-32.
173. Zhu, D., C. Hu, W. Sheng et al. 2009. NAD(P)H oxidase-mediated reactive oxygen species production alters astrocyte membrane molecular order via phospholipase A2. Biochem J 421:201-10.
174. Zhu, D., K. S. Tan, X. Zhang, A. Y. Sun, G. Y. Sun, and J. C. Lee. 2005. Hydrogen peroxide alters membrane and cytoskeleton properties and increases intercellular connections in astrocytes. J Cell Sci 118:3695-703.